Tudor Investment Corp’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-87,974
Closed -$2M 2692
2024
Q2
$2M Buy
+87,974
New +$2.03M 0.01% 1064
2024
Q1
Sell
-27,247
Closed -$972K 2207
2023
Q4
$972K Sell
27,247
-60,370
-69% -$2.25M 0.01% 1459
2023
Q3
$3.84M Buy
+87,617
New +$4.27M 0.04% 617
2019
Q4
Sell
-35,682
Closed -$890K 1138
2019
Q3
$890K Buy
35,682
+8,764
+33% +$250K 0.03% 537
2019
Q2
$803K Sell
26,918
-18,834
-41% -$550K 0.02% 570
2019
Q1
$1.23M Buy
45,752
+6,844
+18% +$208K 0.05% 409
2018
Q4
$1.19M Buy
38,908
+11,115
+40% +$346K 0.02% 335
2018
Q3
$974K Buy
27,793
+250
+0.9% +$7.92K 0.02% 474
2018
Q2
$745K Buy
27,543
+1,366
+5% +$32.1K 0.03% 535
2018
Q1
$537K Buy
26,177
+2,499
+11% +$45.1K 0.02% 542
2017
Q4
$432K Buy
23,678
+5,984
+34% +$118K 0.01% 667
2017
Q3
$396K Buy
17,694
+7,259
+70% +$164K 0.01% 724
2017
Q2
$253K Buy
+10,435
New +$222K 0.01% 813
2017
Q1
Sell
-12,903
Closed -$253K 1366
2016
Q4
$253K Buy
+12,903
New +$234K 0.01% 1097

Other funds holding ATRC

Tudor Investment Corp's ATRC Position: Q3 2024 in Review

Tudor Investment Corp sold out of AtriCure (ATRC) in Q3 2024, closing a stake of 87,974 shares — an estimated $2M sold.

Tudor Investment Corp first reported a position in ATRC in Q4 2016 and held it in 14 quarters. The position peaked at $3.84M in Q3 2023. 201 funds tracked by Wall St. Rank hold ATRC as of Q3 2024.

  • Tudor Investment Corp reported no remaining AtriCure position as of Q3 2024 after selling out during the quarter.
  • Tudor Investment Corp sold 87,974 AtriCure shares in Q3 2024, an estimated $2M.
  • Tudor Investment Corp first reported a position in AtriCure in Q4 2016 and held it in 14 quarters.
  • Tudor Investment Corp's AtriCure position peaked at $3.84M in Q3 2023.
  • 201 funds tracked by Wall St. Rank held AtriCure as of Q3 2024.

Based on Tudor Investment Corp's 13F filing for Q3 2024, filed 14 Nov 2024.